Hideo Miyakoshi
Ajinomoto
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hideo Miyakoshi.
Japanese Journal of Cancer Research | 1991
Ryuichi Fujino; Katsuhito Kawato; Mikio Ikeda; Hideo Miyakoshi; Mikio Mizukoshi; Joko Imai
Partial modifications of antigen components were made to improve the gelatin particle agglutination (PA) test for the detection of antibodies against human T cell leukemia virus type‐I. Envelope glycoproteins prepared by lentil lectin affinity chromatography were further added to the purified viral antigens to be coated on the gelatin particles. Comparative studies with a conventional PA test kit (Serodia ATLA) and indirect immunofluorescence assay showed that the specificity and sensitivity of the new PA test were increased and that abnormal agglutination such as the prozone phenomenon was abolished by this improvement.
International Journal of Immunopharmacology | 1984
Hideo Miyakoshi; Tadao Aoki
The immunopotentiating activity and acting mechanisms of Lentinan were investigated in the human system, resulting in clarification of the following characteristics. (a) Augmentation of DNA synthesis of peripheral mononuclear cells (PMNC) occurred both in vitro and in vivo by adding or injecting Lentinan, for which the coexistence of T cells, B cells and adherent cells (mainly monocytes) was essential. (b) No additional mitogenic effect of Lentinan was observed when PMNC were incubated with both Lentinan and other mitogens. (c) In vitro production of immunoglobulin by PMNC induced with pokeweed mitogen was enhanced through the inhibition of suppressor T cell activity by Lentinan.
NK Cells and Other Natural Effector Cells | 1982
Tadao Aoki; Hideo Miyakoshi; Yoh Horikawa; Akira Shibata; Yoshitaka Aoyagi; Mikio Mizukoshi
Publisher Summary This chapter focuses on interaction between interferon and natural killer (NK) cells in humans after administration of immunomodulating agents. In a styudy described in the chapter, NK activity was readily enhanced, following an increase in the interferon (IFN) titers by Lentinan administration, whereas no significant activation of NK cells was observed even when IFN titers were elevated by Staphage Lysate (SPL) administration. International units of IFN in the body fluid were determined by measuring its inhibitory activity against cytopathic effects of vesicular stomatitis virus (VSV). By sequential measurements of NK activity and IFN titers after Lentinan administration, the peaks of IFN appeared at 12–24 h and NK activity gradually increased in inverse proportion to a decrease in IFN titers, peaking at 24–48 h. To interpret dissociation between the peaks of IFN titers and NK activity, it would be one possible explanation that IFN-activated NK cells gathered and infiltrated into the malignant tissues just after the IFN production by Lentinan administration, resulting in no detection of effective NK cells in the peripheral blood. It seems most likely that this IFN or IFN-like substance produced by SPL affects virus replication but does not activate NK cells.
Clinical Immunology and Immunopathology | 1993
Tadao Aoki; Hideo Miyakoshi; Yoshimaru Usuda; Ronald B. Herberman
International Journal of Immunopharmacology | 1984
Hideo Miyakoshi; Tadao Aoki; Mikio Mizukoshi
International Journal of Cancer | 1984
Hideo Miyakoshi; Hiroko Koide; Tadao Aoki
International Journal of Cancer | 1984
Tadao Aoki; Chuya Hamada; Shigeko Ohno; Hideo Miyakoshi; Hiroko Koide; Marjorie Robert-Guroff; Robert C. Ting; Robert C. Gallo
International Journal of Cancer | 1985
Tadao Aoki; Hideo Miyakoshi; Hiroko Koide; Tsutomu Yoshida; Hiroshi Ishikawa; Yuji Sugisaki; Mikio Mizukoshi; Kazue Tamura; Hirondo Misawa; Chuya Hamada; Robert C. Ting; Marjorie Robert-Guroff; Robert C. Gallo
The Lancet | 1984
Tadao Aoki; Hideo Miyakoshi; Yoshimaru Usuda; Jean-Claude Chermann; Francois Barré-Sinoussi; RobertC. Ting; Robert C. Gallo
Archive | 1994
Tadao Aoki; Hideo Miyakoshi